Please select the eligibility criteria that correspond to the clinical trial below.
Title: International Latino Research Partnership
Brief Summary: Through a grant funded by the National Institute on Drug Abuse (NIDA) the Center for Multicultural Mental Health Research at Cambridge Health Alliance is testing a screening and intervention project designed to improve the quality of care for Latino patients with comorbid mental health and substance use problems. We will first test a screening of comorbid problems with patients identified in mental health as well as primary health care. Building on that work, we will test the feasibility, acceptability and efficacy of the "Integrated Intervention for Dual Problems and Early Action" (IIDEA) intervention addressing mental health, substance use, and prevention of HIV, as well as a smoking cessation supplement. The project is being conducted in Massachusetts as well as at two sites in Spain. As such, the proposed ILRP multi-site international project is a critical step towards developing models of integrated care for the large and diverse Latino migrant population and more broadly towards understanding how best to integrate evidence-based assessment and treatments for co-occurring substance and mental health problems and HIV risks.


Options:
A: Inclusion Criteria:

* completion or scheduled completion (i.e., within 2 weeks) of Inpatient or Intensive Outpatient treatment
* fluency in English
* enrollment in a substance abuse aftercare program
* medical clearance by referring provider
* willingness to accept random assignment to treatment condition

Exclusion Criteria:

* already participated in the pilot MBRP trial conducted by this research team
* participation in the comorbid disorders or relapse prevention groups offered at partner agency
* comorbid psychosis (including schizophrenia, schizoaffective or other schizophreniform disorder)and/or dementia, acute suicidality/intent to harm others, severe cognitive impairment, and high risk of withdrawal or medical complications stemming from relapse which would require a higher level of care.
B: Inclusion Criteria:

* Latino migrants
* Must speak English or Spanish
* 18-70 years of age
* Screen positive to at least one substance use and one mental health problem

Exclusion Criteria:

* Current or recent (last 3 months) substance use treatment (more than 1 visit with a provider at a behavioral health clinic)
* Planning to receive behavioral health services (i.e., have an appointment scheduled in the next 2 months)
* Evidence that the patient lacks capacity to consent to the study
* Evidence of current suicidal risk or harm to others (affirmative responses to questions 4 and/or 5 on Paykel suicide questionnaire)- patient can be rescreened in 30 days
C: Inclusion Criteria:

* Age 18-60+
* Current chronic pain condition
* Current use of prescription opioid agonist or mixed agonist-antagonist analgesics for \>90 days

Exclusion Criteria:

* Prior experience with Mindfulness-Based Stress Reduction, Mindfulness-Based Cognitive Therapy, or Mindfulness-Based Relapse Prevention
* Active suicidality, schizophrenia, psychotic disorder, and/or severe substance dependence (other than opioid dependence)
* Opioid misuse as determined by Current Opioid Misuse Measure
D: Inclusion Criteria:

* chronic pain diagnosis (ICD-9 diagnoses 338.xx)
* treatment with prescription opioids for \> 3 months

Exclusion Criteria:

* prior mindfulness training
* persons who are experiencing acute opioid withdrawal
* suicidal ideation
* psychosis

Answer: B